In conclusion, DMRTA2 activates the p53 pathway by binding to HSP90β, inhibiting its ubiquitination and nuclear export of p53, and suppressing the proliferation and invasion of lung cancer cells (Figure 13C). Here, TP53 is linked to lung cancer.